A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2011
11/17/2011	WO2011062955A3 Compounds for modulating tlr2
11/17/2011	WO2011060104A3 Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic agents to rgd binding sites
11/17/2011	WO2011006914A3 Antagonists, uses & methods for partially inhibiting tnfr1
11/17/2011	US20110282464 Reactive Surgical Implants
11/17/2011	US20110281914 Fentanyl composition for nasal administration
11/17/2011	US20110281911 Novel forms of eperisone
11/17/2011	US20110281897 Heterocyclic compounds and their uses
11/17/2011	US20110281892 Method and formulation for cold treatment in adults and children with increased safety
11/17/2011	US20110281891 N-hydroxyamide derivatives and use thereof
11/17/2011	US20110281886 Pharmaceutical Compositions with Attenuated Release of Phenolic Opioids
11/17/2011	US20110281885 Therapeutic agents useful for treating pain
11/17/2011	US20110281884 Fused derivatives as pi3kdelta inhibitors
11/17/2011	US20110281882 Compositions and Methods for Treating, Controlling, Reducing, or Ameliorating Inflammatory Pain
11/17/2011	US20110281879 Sulfonyl containing compounds as cysteine protease inhibitors
11/17/2011	US20110281878 INHIBITORS OF p38
11/17/2011	US20110281876 Therapeutic agents useful for treating pain
11/17/2011	US20110281873 Pyrimidine Compounds and Methods of Making and Using Same
11/17/2011	US20110281870 Novel substituted octahydrocyclopenta[c]pyrrol-4-amines as calcium channel blockers
11/17/2011	US20110281866 Heterocyclic kinase inhibitors
11/17/2011	US20110281865 Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5- disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
11/17/2011	US20110281864 Pyrido[3,2-d]Pyridazine-2(1H)-One Compounds as p38 Modulators and Methods of Use Thereof
11/17/2011	US20110281859 Novel heterocyclic compounds as metap-2 inhibitors
11/17/2011	US20110281857 Pi3k/mtor kinase inhibitors
11/17/2011	US20110281855 Novel and potent tapentadol dosage forms
11/17/2011	US20110281854 Morpholine compounds
11/17/2011	US20110281848 Imidazole compounds having pharmaceutical activity towards the sigma receptor
11/17/2011	US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/17/2011	US20110281840 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
11/17/2011	US20110281838 5-alkynyl-pyrimidines
11/17/2011	US20110281837 3-substituted-6-aryl pyridines
11/17/2011	US20110281836 Silent desensitizers of neuronal NACHR and methods of use thereof
11/17/2011	US20110281834 Pharmaceutical Formulations for Iontophoretic Delivery of a Corticosteroid
11/17/2011	US20110281832 Organic compounds
11/17/2011	US20110281831 Novel dermaceutical cream made using sodium fusidate, antifungals and steroids
11/17/2011	US20110281830 Novel dermaceutical cream made using sodium fusidate and steroids
11/17/2011	US20110281827 Compositions, gels and foams with rheology modulators and uses thereof
11/17/2011	US20110281822 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity
11/17/2011	US20110281812 Compounds
11/17/2011	US20110281811 Use Of Leukotriene Inhibitors For Treating Lung Diseases In Prematurely Born Infants
11/17/2011	US20110281809 Methods and compositions for rapid treatment of otitis externa
11/17/2011	US20110281292 Compositions and methods for identifying antigens which elicit an immune response
11/17/2011	US20110280966 Dosing regimens and methods of treatment using carbon monoxide
11/17/2011	US20110280965 Materials and methods of using calcium for reduction of inflammation
11/17/2011	US20110280960 Thick pine needle extract composition for capsulation
11/17/2011	US20110280952 Platelet Lysate and Bioadhesive Compositions Thereof for the Treatment of Mucositis
11/17/2011	US20110280929 Sirna of nf-kb p105 for inhibiting cell proliferation and migration and a composition comprising same
11/17/2011	US20110280927 Composition and dressing with nitric oxide
11/17/2011	US20110280908 Multimeric protein toxins to target cells having multiple identifying characteristics
11/17/2011	US20110280882 Leukolectins and uses thereof
11/17/2011	US20110280876 Mutated netrin - 4, fragments thereof and their use as medicines
11/17/2011	US20110280875 Antibodies which bind human cxcr3
11/17/2011	US20110280873 MCP1-Ig FUSION VARIANTS
11/17/2011	US20110280871 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/17/2011	US20110280869 Methods of preventing or treating inflammatory or autoimmune disorders by administering cd2 antagonists in combination with other prophylactic or therapeutic agents
11/17/2011	US20110280855 Vitamin c compositions
11/17/2011	US20110280848 Composition comprising chicoric acid and/or derivatives thereof
11/17/2011	US20110280836 Compositions for bacterial mediated gene silencing and methods of using the same
11/17/2011	US20110280832 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
11/17/2011	US20110280831 Combinations comprising methotrexate and dhodh inhibitors
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	US20110280828 Methods for treatment of microbial disorders
11/17/2011	US20110280799 Nanocells for diagnosis and treatment of diseases and disorders
11/17/2011	DE102010022174A1 Neue Darreichungsformen für Cineol New forms of cineole
11/17/2011	DE102010020567A1 Metallkomplexe Metal complexes
11/17/2011	CA2805086A1 Antisense modulation of interleukins 17 and 23 signaling
11/17/2011	CA2799168A1 Methods of control and prophylaxis of inflammation and mitigation of inflammatory conditions in companion animals
11/17/2011	CA2799146A1 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
11/17/2011	CA2798895A1 Modulation of splenocytes in cell therapy
11/17/2011	CA2784666A1 Modified clostridial toxins comprising an integrated protease cleavage site-binding domain
11/16/2011	EP2386575A2 Dual specificity antibodies and methods of making and using
11/16/2011	EP2386566A2 Chi-conotoxin peptides (II)
11/16/2011	EP2386565A2 Compounds and methods to inhibit or augment an inflammatory response
11/16/2011	EP2386558A1 CGRP antagonists
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP1885722B1 Quinoline derivatives as ep4 antagonists
11/16/2011	EP1542657B1 Cannabinoid liquid formulations for mucosal amdinistration
11/16/2011	EP1506166B1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/16/2011	CN202036382U Collar for treating cervical spondylosis
11/16/2011	CN1931228B Lysimachia herb total flavone extract and its preparation process
11/16/2011	CN1925846B Use of a 5-HT3 receptor antagonist for the manufacture of a medicament for the treatment of non-digestive tract derived abdominal disorders associated with pain
11/16/2011	CN102245602A Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis
11/16/2011	CN102245586A Thiadiazole-substituted arylamides
11/16/2011	CN102245176A Fatty acids for use as a medicament
11/16/2011	CN102242154A Liquid fermentation method for producing paecilomyces cicadae mycelia and application of culture product
11/16/2011	CN102242152A Humic acid active component and preparation method, application and pharmaceutical composition thereof
11/16/2011	CN102242079A Medium for producing Paecilomyces cicadae spore, culture method thereof, culture product thereof and application thereof
11/16/2011	CN102242070A Method for artificially culturing paecilomyces cicadae and application of culturing product thereof
11/16/2011	CN102242069A Paecilomycescicadae (Miq.)Samson and application thereof
11/16/2011	CN102241776A RANKL-TNF (Receptor Activator of Nuclear Factor Kappa-B Ligand-Tumour Necrosis Factor) sample region fusion protein and preparation method and application thereof
11/16/2011	CN102241737A Endomorphin-1 analogs, synthesis thereof and application of endomorphin-1 analogs in preparation of analgesic medicines
11/16/2011	CN102241678A Antitumor effect and application of alicyclic structure-containing compound
11/16/2011	CN102241633A Linolenic acid-carnosine composite and preparation method thereof
11/16/2011	CN102241621A 5,5-disubstituted-2-iminopyrrolidine derivatives, preparation method thereof, and medical applications thereof
11/16/2011	CN102241596A O-aminoalcohol compounds, preparation method thereof and application thereof
11/16/2011	CN102240391A Traditional Chinese medicine solution for health promotion
11/16/2011	CN102240389A Medicament for treating arthralgia due to wind-cold-dampness
11/16/2011	CN102240383A Traditional Chinese medicine composition for treating dysmenorrhea
11/16/2011	CN102240367A Blood circulation promoting and vein relaxing preparation
11/16/2011	CN102240356A Powder for treating cervical spondylosis, intervertebral disc herniation, ankylosing spondylitis and hyperosteogeny
11/16/2011	CN102240351A Traditional Chinese medicine for treating Arthritis, hyperosteogeny, cervical disc herniation and cervical spondylosis

1 ... 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 ... 1272